Item 8.01 Other Information.



On January 22, 2020, SI-BONE, Inc. (the "Company") entered into an Underwriting
Agreement (the "Underwriting Agreement") with Morgan Stanley & Co. LLC and BofA
Securities, Inc., representatives of the several underwriters (the
"Underwriters"), and certain shareholders of the Company (the "Selling
Shareholders") relating to the offering and sale (the "Offering") of 4,300,000
shares of the Company's common stock, par value $0.0001 per share. Of these
shares, 1,809,947 shares were offered by the Selling Shareholders, and 2,490,053
shares were offered by the Company. The price to the public in the Offering is
$21.50 per share of common stock. Pursuant to the Underwriting Agreement, the
Underwriters have a 30-day option to purchase up to an additional 645,000 shares
of common stock from the Company on the same terms and conditions. The Offering
is scheduled to close on January 27, 2020, subject to the satisfaction of
customary closing conditions. The shares of common stock are listed on The
Nasdaq Global Market.
The Offering is being made pursuant to the Company's effective shelf
registration statement on Form S-3 (Registration No. 333-235714) filed with the
Securities and Exchange Commission (the "SEC") on December 27, 2019, and
declared effective on January 2, 2020. The Company filed with the SEC a
preliminary prospectus supplement, dated January 21, 2020, and a final
prospectus supplement, dated January 22, 2020, relating to the offer and sale of
the shares.
Morgan Stanley and BofA Securities are acting as joint book-running managers.
Canaccord Genuity LLC and JMP Securities LLC are acting as co-managers.
The Underwriting Agreement contains customary representations, warranties and
agreements by the Company and the Selling Shareholders, customary conditions to
closing, indemnification obligations of the Company, the Selling Shareholders
and the Underwriters, including for liabilities under the Securities Act of
1933, as amended, other obligations of the parties and termination provisions.
The representations, warranties and covenants contained in the Underwriting
Agreement were made only for purposes of such agreement and as of specific
dates, were solely for the benefit of the parties to such agreement and may be
subject to limitations agreed upon by the contracting parties.
The Underwriting Agreement is filed as Exhibit 1.1 hereto. The foregoing
description of the terms of the Underwriting Agreement is qualified in its
entirety by reference to such exhibit. A copy of the opinion of Cooley LLP
relating to the shares in the Offering is attached as Exhibit 5.1 hereto.

Item 9.01 - Financial Statements and Exhibits.



Exhibit No.                                 Description

                Underwriting Agreement, dated January 22, 2020  , by and among the
              Company, Morgan Stanley & Co. LLC and BofA Securities, Inc., as
    1.1       representatives of the several underwriters named on Schedule II
              thereto, and certain shareholders of the Company named on Schedule I
              thereto.
    5.1         Opinion of Cooley LLP
   23.1         Consent of Cooley LLP   (contained in Exhibit 5.1)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses